Clinical Trial Update: Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating buffered lidocaine to reduce pain during prostate biopsy has completed, sponsored by the University of Washington.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Buffered Lidocaine (lidocaine (buffered formulation))

Snippet

Sponsor: University of Washington | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED